3rd Quarter - Report

JOHNSON & JOHNSON SERVICES, INC. for JOHNSON & JOHNSON SERVICES INC

Firm
Client
Income
—
Expenses
$780,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

9 issue areas, each in the filer's own words, with who lobbied on it and where.

Trade (domestic/foreign) TRD

- Issues related to Trade Promotion Authority. - Issues related to Trans-Pacific Partnership agreement. - Issues related to Transatlantic Trade and Investment Partnership. - Issues related to APEC Healthcare trade project. - Issues related to Trade Promotion Authority. - Issues related to the appointment of a dedicated healthcare trade official

LobbyistCovered position, as disclosed
DAVID KAVANAUGH —

Contacted: SENATE; U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES

Taxation/Internal Revenue Code TAX

- HR 1270/S 709, "Restoring Access to Medication Act of 2015", regarding all provisions. - Issues related to tax reform. - Issues related to Look through permanency. - Issues related to R&D credit permanency. - Issues related to Mobile Workforce. - Issues related to Cadillac Tax. - Issues related to OECD tax reports. - Issues related to Repatriation holiday.

LobbyistCovered position, as disclosed
DARREL C JODREY —
DAVID KAVANAUGH —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; U.S. Trade Representative (USTR)

Bills named: H.R. 1270 (114th)

Copyright/Patent/Trademark CPT

- HR 9, "Goodlatte Innovation Act", regarding all provisions - S 632, "STRONG Patents Act of 2015", regarding all provisions - Issues related to the re-introduction of the Patent Abuse Act

LobbyistCovered position, as disclosed
CHARLES NAU —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; U.S. Trade Representative (USTR)

Bills named: H.R. 9 (114th)

Medicare/Medicaid MMM

- HR 1427/S 804, "Medicare CGM Access Act of 2015", regarding all provisions. - HR 284, "Medicare DMEPOS Competitive Bidding Improvement Act of 2015", regarding all provisions. - Issues regarding combination products. - Issues regarding Transferable Regulatory Exclusivity Incentive.

LobbyistCovered position, as disclosed
JANE MARGARET ADAMS —
MARK REESE —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR)

Bills named: H.R. 1427 (114th), H.R. 284 (114th)

Budget/Appropriations BUD

- HR 83, "Consolidate and Further Continuing Appropriations Act, 2015", provisions related to emergency supplemental funding to address the Ebola epidemic domestically and internationally. - Issues related to the funding of the Biomedical Advanced Research and Development Authority. - FDA Funding.

LobbyistCovered position, as disclosed
BRIAN BURNS —
DARREL C JODREY —
CHARLES NAU —

Contacted: HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); SENATE

Bills named: H.R. 83 (114th)

Animals ANI

- Issues relating to animal testing.

LobbyistCovered position, as disclosed
DARREL C JODREY —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; U.S. Trade Representative (USTR)

Insurance INS

- S 620, "Preserving Employee Wellness Programs Act", regarding all provisions.

LobbyistCovered position, as disclosed
DARREL C JODREY —

Contacted: HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); SENATE

Health Issues HCR

- H 2, "Medicare Access and CHIP Reauthorization Act of 2015", regarding all provisions. - HR 1078, "Food and Drug Administration Safety Over Sequestration Act of 2015", regarding all provisions. - S 1622, "FDA Device Accountability Act of 2015", regarding all provisions. - HR 6, "21st Century Cures Act", regarding all provisions. - S 993, "Comprehensive Justice and Mental Health Act of 2015", regarding all provisions. - Issues related to physician-owned companies that manufacture or distribute medical devices. - Issues relating to cosmetic regulatory reform. - Issues related to 340B payments to hospitals. - Issues related to pseudoephedrine. - Issues related to dextromethorphan. - Issues related to legislation that would modify the Medicare Part B drug reimbursement program. - Issues related to legislation that would establish a rebate in the Medicare Part D program. - Issues related to Pub.L. 108-164, "Fairness to Contact Lens Consumers Act" (FCLCA) and related FTC Contact Lens Rule. - S.2977, "The Medical Electronic Data Technology Enhancement for Consumers' Health" (MEDTECH Act), regarding all provisions. - H.R. 3250, "DXM Abuse Prevention Act of 2015", regarding all provisions. - S. 1767, "The Combination Products Regulatory Fairness Act of 2015", regarding all provisions. - S. 1622, "The FDA Devise Accountablility Act", regarding all provisions. - S. 993, "Comprehensive Justice and Mental Health Act of 2015", regarding all provisions. - HR 2646, "Helping Families in Mental Health Crisis Act of 2015", regarding all provisions. - HR 1854, "Comprehensive Justice and Mental Health Act of 2015", regarding all provisions.

LobbyistCovered position, as disclosed
JANE MARGARET ADAMS —
ANNE BRUCE —
BRIAN BURNS —
LAURYL DODSON JACKSON —
DARREL C JODREY —
BRIAN T KELLY —
CHARLES NAU —
MARK REESE —

Contacted: U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 1622 (114th), H.R. 2646 (114th), H.R. 6 (114th), S. 2977 (114th), H.R. 1078 (114th), S. 993 (114th), H.R. 3250 (114th), H.R. 1854 (114th), S. 1767 (114th)

Environment/Superfund ENV

- HR 1321, "Microbead-Free Waters Act of 2015", regarding all provisions. - S 697, "Frank R. Lautenberg Chemical Safety for the 21st Century Act", regarding all provisions.

LobbyistCovered position, as disclosed
DARREL C JODREY —

Contacted: HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); SENATE

Bills named: H.R. 1321 (114th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.